{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:20:37Z","timestamp":1670332837901},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.transci.2011.11.013","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T04:40:05Z","timestamp":1324615205000},"page":"67-71","source":"Crossref","is-referenced-by-count":3,"title":["Soluble CD40 ligand, high sensitive C-reactive protein and fetuin-A levels in patients with essential thrombocythemia"],"prefix":"10.1016","volume":"46","author":[{"given":"Ferda","family":"Bilgir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oktay","family":"Bilgir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Kebapcilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Calan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusun","family":"Ozdemirkiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turker","family":"Cinali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giray","family":"Bozkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2011.11.013_b0005","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.beha.2005.07.011","article-title":"Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention","volume":"19","author":"Landolfi","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.transci.2011.11.013_b0010","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1182\/blood-2008-06-164087","article-title":"Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera","volume":"112","author":"Marchetti","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.11.013_b0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajh.21338","article-title":"Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden","volume":"84","author":"Arellano-Rodrigo","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2011.11.013_b0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2011.11.013_b0025","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2006-09-046342","article-title":"Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status","volume":"109","author":"Carobbio","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.11.013_b0030","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1538-7836.2007.02626.x","article-title":"Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7 F status, clonality, and antiphospholipid antibodies","volume":"5","author":"Robertson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2011.11.013_b0035","first-page":"336","article-title":"Interactions of neutrophils and coagulation proteins","volume":"34","author":"Gillis","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2011.11.013_b0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.exphem.2007.01.053","article-title":"V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules","volume":"35","author":"Falanga","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.transci.2011.11.013_b0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/pgmj.59.691.304","article-title":"Alpha 2HS-glycoprotein in the serum and urine of patients with renal diseases","volume":"59","author":"Kishore","year":"1983","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.transci.2011.11.013_b0050","doi-asserted-by":"crossref","first-page":"14429","DOI":"10.1073\/pnas.95.24.14429","article-title":"Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules","volume":"95","author":"Wang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.transci.2011.11.013_b0055","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1681\/ASN.2004100895","article-title":"Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification","volume":"16","author":"Reynolds","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2011.11.013_b0060","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2169\/internalmedicine.49.3223","article-title":"Decreased serum fetuin-A levels are associated with coronary artery diseases","volume":"49","author":"Bilgir","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.transci.2011.11.013_b0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.atherosclerosis.2009.05.018","article-title":"High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population","volume":"207","author":"Rittig","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.transci.2011.11.013_b0070","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2011.11.013_b0075","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1681\/ASN.2005040365","article-title":"Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice","volume":"16","author":"Merx","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2011.11.013_b0080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<548::AID-IMMU548>3.0.CO;2-2","article-title":"Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells","volume":"28","author":"Wykes","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.transci.2011.11.013_b0085","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.CIR.100.6.614","article-title":"Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes","volume":"100","author":"Aukrust","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2011.11.013_b0090","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1182\/blood.V99.7.2612","article-title":"Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis","volume":"99","author":"Viallard","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.11.013_b0095","first-page":"29","article-title":"Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment","volume":"34","author":"Murphy","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2011.11.013_b0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0049-3848(83)90255-4","article-title":"The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration","volume":"32","author":"Martin","year":"1983","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2011.11.013_b0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/euhj.1997.0747","article-title":"Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain","volume":"19","author":"Pizzulli","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transci.2011.11.013_b0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/09537100500220729","article-title":"The mean platelet volume in subjects with impaired fasting glucose","volume":"17","author":"Coban","year":"2006","journal-title":"Platelets"},{"key":"10.1016\/j.transci.2011.11.013_b0115","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.110.216143","article-title":"Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2\/Rac1\/p38 mitogen-activated protein kinase signaling pathway","volume":"30","author":"Yacoub","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.transci.2011.11.013_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09513590.2010.491164","article-title":"Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients","volume":"27","author":"Kebapcilar","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.transci.2011.11.013_b0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00024382-200115030-00004","article-title":"Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan","volume":"15","author":"Ombrellino","year":"2001","journal-title":"Shock"},{"key":"10.1016\/j.transci.2011.11.013_b0130","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/01.CIR.95.4.778","article-title":"Cytokines and cardiac contractile function","volume":"95","author":"Kelly","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2011.11.013_b0135","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.106.682450","article-title":"Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study","volume":"115","author":"Ix","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2011.11.013_b0140","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0735-1097(02)02953-4","article-title":"C-reactive protein and other inflammatory risk markers in acute coronary syndromes","volume":"41","author":"Blake","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transci.2011.11.013_b0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211002187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211002187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T09:57:37Z","timestamp":1543312657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050211002187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1473050211002187"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2011.11.013","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}